Clinical trial

Study of Treatment and Metabolism in Patients With Urea Cycle Disorders

NCT00004307 · National Center for Research Resources (NCRR), NIH · Unknown status

Key facts

NCT number NCT00004307
Title Study of Treatment and Metabolism in Patients With Urea Cycle Disorders
Official title Therapeutic and Metabolic Studies of Urea Cycle Disorders: Part A: Nitrogen Flux and Ureagenesis; Part B (Closed): Phase I Adenovirus Vector-Mediated Gene Therapy for Ornithine Transcarbamylase Deficiency
Lead sponsor National Center for Research Resources (NCRR), NIH
Collaborators Baylor College of Medicine
Status Unknown status
Phase Phase 1
Study type Interventional
Conditions Amino Acid Metabolism, Inborn Errors
Intervention type Behavioral, Genetic
Interventions Protein and calorie controlled diet, Ornithine transcarbamylase vector
Enrollment 66
Start date Dec 1, 1999
First posted Oct 19, 1999
Last update posted Jun 24, 2005
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies